跳至主要内容
临床试验/NCT07595211
NCT07595211尚未招募不适用

Peri-Implant Soft Tissue Management During Second-Stage Surgery With Two Different Flap Techniques: A Randomized Controlled Study

Ohio State University0 个研究点目标入组 16 人开始时间: 2026年6月30日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
16

研究概览

简要总结

Patients are being asked to consider joining a research study that looks at two different ways dentists uncover dental implants during a small gum surgery. To join this study, Patients must have two dental implants that are ready to be uncovered. Both uncovering methods used in this research are normal, safe procedures that dentists already use every day. The purpose of this study is to learn which method helps the gums heal better, stay thicker, and look more natural over time.

If patients decide to participate, the dentist will use one method on one implant and the other method on the second implant so we can compare how each implant heals. The study lasts about one year and includes the uncovering surgery plus scheduled follow-up visits. At these visits, the dentist will gently measure your gums, take pictures, take routine dental X-rays, and use a small camera scanner to check how the gum tissue changes. Patients will also be asked to rate any pain or swelling after surgery.

Patients may have soreness, swelling, or minor bleeding-these are the same risks patients would have during normal implant care. Patients may or may not personally benefit, but the extra monitoring may help us track the healing closely, and patients' participation can help dentists improve care for future patients.

Patients can receive regular implant treatment without joining the study. The goal of this summary is to help you think about the pros and cons and decide what feels right for patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients between the ages of 18-
  • Non-smokers or former smokers with at least a 5-year successful cessation history.
  • Patients with normal systemic health (ASA-I) or well-controlled/stable systemic conditions (ASA-II), such as diabetes with HbA1c < 7.0%, no recent acute myocardial infarction or cerebrovascular accidents within 6 months, or any contraindication for periodontal or implant surgery.
  • Patients who had, or plan to have, 2 non-adjacent implants of the same system placed under a two-stage implant protocol.
  • The diameter discrepancy of the 2 target implants must be less than 1 mm.

排除标准

  • Current smokers, or smokers who have quit <5 years prior to study entry.
  • Pregnant or lactating women
  • Patients with substance or alcohol abuse
  • Patients with a history of antiresorptive therapy, head and neck radiotherapy, and chemotherapy for malignant tumors
  • Other systemic conditions or medication affecting wound healing.
  • Poor plaque control with plaque score > 20%
  • Active/untreated odontogenic and periodontal infections
  • Implants placed, or planned to be placed, with one-stage implant protocol.
  • The diameter discrepancy of the 2 target implants is equal to or greater than 1 mm (≥ 1 mm).
  • Implants showing signs of early peri-implant bone loss or infection.
  • Severe loss of keratinized tissue (> 50%) at the implant site
  • Non-English speaking individuals for studies involving informed consent.

研究者

申办方类型
Other
责任方
Sponsor

相似试验